Results 201 to 210 of about 44,813 (273)

Pichia pastoris, una alternativa para la producción de glicoproteínas humanas de uso terapéutico. Estrategias de fermentación [PDF]

, 2003
Henry Córdoba Ruiz, Néstor Algecira Encizo, Raúl Poutou Piñales, Luis Alejandro Barrera Avellaneda   +3 more
openalex  

Activity Expression and Property Analysis of Codon-Optimized Polyphenol Oxidase from <i>Camellia sinensis</i> in <i>Pichia pastoris</i> KM71. [PDF]

Foods
Zhang X, Xu YQ, Yin JF, Zou C.
europepmc   +1 more source

Pichia pastoris-Derived β-Glucan Capsules as a Delivery System for DNA Vaccines. [PDF]

Vaccines (Basel)
Pinho SS, Invenção MDCV, Silva AJD, Macêdo LS, Espinoza BCF, Leal LRS, da Gama MATM, Moura IA, Silva MEDS, Souza DVS, Lara ML, Alves JNSA, Freitas AC.   +12 more
europepmc   +1 more source

Heterologous expression of novel endoglucanases from Myceliophthora heterothallica in Pichia pastoris and Escherichia coli

, 2016
Carolina Bezerra [UNESP] Bussoli
openalex   +1 more source

Combined strategies for improving production of a thermo-alkali stable laccase in Pichia pastoris

, 2017
Jiayi Wang, Lei Lu, Fujuan Feng
openalex   +1 more source

Fusion Partner Facilitates Expression of Cell-Penetrating Peptide L2 in Pichia pastoris. [PDF]

Antibiotics (Basel)
Li X, Yang N, Fang Y, Mao R, Hao Y, Teng D, Dong N, Shan A, Wang J.   +8 more
europepmc   +1 more source

Streamlined production of immobilized D-psicose 3-epimerase via secretion in Pichia pastoris: a new paradigm for industrial D-psicose production. [PDF]

Microb Cell Fact
Srila P, Pinmanee P, Ninchan B, Watthanasakphuban N.   +3 more
europepmc   +1 more source

Efficient expression and purification of rat CRP in Pichia pastoris. [PDF]

Front Immunol
Cheng B, Tang YL, Gou YF, Li JY, Xu TH, Zhu L.   +5 more
europepmc   +1 more source

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris. [PDF]

Microb Biotechnol
Kalyoncu S, Sayili D, Kuyucu AZ, Soyturk H, Gullu S, Ersayan B, Tarman IO, Avci ME, Mert O, Haskok U, Tekin E, Akinturk H, Orkut R, Demirtas A, Tilmensagir I, Ulker C, Gungor B, Inan M.   +17 more
europepmc   +1 more source

Safety, tolerability and immunogenicity of a quadrivalent recombinant norovirus vaccine (Pichia pastoris) in participants six weeks of age or older: Phase I/IIa trial. [PDF]

Emerg Microbes Infect
Chen G, Shi L, Yu Q, Liu Q, Wang X, Liu Y, Ding F, Yuan L, Wang P, Zhou X, Zhang Y, Huang Z, Li J, Hu Z, Huang T.   +14 more
europepmc   +1 more source